Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Prim Care Community Health ; 14: 21501319231162308, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36960553

RESUMO

OBJECTIVE: The purpose of this feasibility pilot study was to evaluate safety and adherence of a wearable brain sensing wellness device designed to reduce stress among healthcare professionals (HCP). METHODS: A total of 40 HCP were invited to participate in an open-label pilot study. Participants were asked to use a brain sensing wearable device (MUSE-S™) on a daily basis to reduce their stress, for a total of 90 days. Total study participation duration was 180 days. Study enrollment began in August 2021 and ended December 2021. The exploratory outcomes included stress, depression, sleep, burn-out, resilience, quality of life, and cognition. RESULTS: Among the 40 HCP in study, the majority were female (85%), white (87.5%) and with an average age of 41.3 ± 11.0 years (SD). Participants used the wearable device an average of 23.8 times over a 30-day period with a mean duration of 5.8 min with each use. Study results demonstrate the positive impact of guided mindfulness using the wearable device MUSE-S™ and its accompanying application (APP). A statistically significant improvement was found for a reduction in stress (P < .001) and improvement in resilience (P = .02), quality of life (P = .003), and cognition (P < .001). The majority (91.9%) of the participants indicated they felt more relaxed after using the device, and 73% indicated they would continue to use this device at end-of-study. No adverse effects were reported. CONCLUSION: Study results show that 3 to 10 min of guided meditation during work hours through the use of a brain sensing wearable device is safe and acceptable, with associated health benefits for HCP.


Assuntos
Atenção Plena , Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Projetos Piloto , Atenção Plena/métodos , Qualidade de Vida , Pandemias , Alprostadil , Pessoal de Saúde , Encéfalo
2.
Mayo Clin Proc ; 95(8): 1594-1603, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32753134

RESUMO

OBJECTIVE: To examine differences in the frequency and severity of federally reported adverse events between caffeine-containing and non-caffeine-containing products while also identifying the category of caffeine-containing products associated with the highest frequency and severity of adverse events. PATIENTS AND METHODS: All adverse event reports that met specified eligibility criteria and were submitted to the Center for Food Safety and Applied Nutrition Adverse Event Reporting System between January 1, 2014, and June 29, 2018, were extracted. In this retrospective observational study, the most severe adverse event experienced, an ordinal variable, was categorized into death, life-threatening, hospitalization/disability, and emergency department visit. A nonproportional odds model was used to compare the odds of caffeine-containing products being associated with more severe adverse events relative to a noncaffeine group. The analysis is of data only from those reporting adverse events and may or may not be representative of the entire population exposed to these products, which is not known from the examined data. RESULTS: Energy and preworkout products saw a significant increase in the odds of the adverse event experienced being death rather than the other less severe outcomes relative to the noncaffeinated group. Those products, along with weight loss products, had greater odds of the adverse event being death or life-threatening vs the less severe outcomes relative to the noncaffeinated group. CONCLUSION: Caffeine-containing products have a greater association with severe adverse events compared with non-caffeine-containing products. Exposure to preworkout and weight loss products had greater odds of being associated with a more serious adverse event relative to noncaffeinated products. Health care practitioners should use these outcomes to better inform and educate patients about the many factors related to caffeine intake and adverse outcomes.


Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos/estatística & dados numéricos , Cafeína/efeitos adversos , United States Food and Drug Administration , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Fármacos Antiobesidade/efeitos adversos , Fármacos Antiobesidade/toxicidade , Cafeína/toxicidade , Bebidas Gaseificadas/efeitos adversos , Bebidas Gaseificadas/toxicidade , Criança , Pré-Escolar , Café/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Suplementos Nutricionais/toxicidade , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Chá/efeitos adversos , Estados Unidos , Adulto Jovem
3.
J Altern Complement Med ; 26(7): 602-609, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32673082

RESUMO

Objectives: Integrative therapies have been incorporated increasingly into health and wellness in the United States in recent decades. Their potential benefits are under evaluation in various situations, including pain and symptom relief for cancer patients and survivors. This pilot study evaluated whether combining two integrative complementary approaches augments a patient's benefit by reducing postoperative stress, pain, anxiety, muscle tension, and fatigue compared with one integrative complementary approach alone. Design: Patients undergoing autologous tissue breast reconstruction were randomly assigned to one of two postoperative complementary alternative therapies for three consecutive days. All participants were observed for up to 3 months. Subjects: Forty-two participants were recruited from January 29, 2016 to July 11, 2018. Interventions: Twenty-one participants were randomly assigned to massage alone and 21 to massage and acupuncture. Outcome measures: Stress, anxiety, relaxation, nausea, fatigue, pain, and mood (score 0-10) were measured at enrollment before surgery and postoperative days 1, 2, and 3 before and after the intervention. Patient satisfaction was evaluated. Results: Stress decreased from baseline for both Massage-Only Group and Massage+Acupuncture Group after each treatment intervention. Change in stress score from baseline decreased significantly more in the Massage-Only Group at pretreatment and posttreatment (p = 0.03 and p = 0.04). After adjustment for baseline values, change in fatigue, anxiety, relaxation, nausea, pain, and mood scores did not differ between groups. When patients were asked whether they would recommend the study, 100% (19/19) of Massage-Only Group and 94% (17/18) of Massage+Acupuncture Group responded yes (p = 0.49). Conclusion: No additive beneficial effects were observed with addition of acupuncture to massage for pain, anxiety, relaxation, nausea, fatigue, and mood. Combined massage and acupuncture was not as effective in reducing stress as massage alone, although both groups had significant stress reduction. These findings indicate a need for larger studies to explore these therapies further.


Assuntos
Terapia por Acupuntura , Neoplasias da Mama/cirurgia , Massagem , Procedimentos de Cirurgia Plástica/efeitos adversos , Cuidados Pós-Operatórios/métodos , Período Pós-Operatório , Adulto , Afeto , Idoso , Ansiedade/etiologia , Ansiedade/prevenção & controle , Neoplasias da Mama/complicações , Neoplasias da Mama/psicologia , Terapia Combinada , Fadiga/etiologia , Fadiga/prevenção & controle , Feminino , Humanos , Pessoa de Meia-Idade , Náusea/etiologia , Náusea/prevenção & controle , Dor/etiologia , Dor/prevenção & controle , Manejo da Dor , Satisfação do Paciente , Projetos Piloto , Procedimentos de Cirurgia Plástica/psicologia , Relaxamento , Estresse Psicológico/etiologia , Estresse Psicológico/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA